Pulmonary complications

Tarek Eid, Alan F. Barker

Research output: Chapter in Book/Report/Conference proceedingChapter


After hematopoietic stem cell transplant (HSCT), up to 60% of patients develop pulmonary complications. In spite of antibacterial, antiviral, and antifungal prophylaxis, reduced host defenses render the HSCT patient vulnerable to pulmonary and other infections in the early weeks and even months post-transplantation. This chapter will suggest an integrative approach followed by a description of the most common pulmonary syndromes seen in HSCT patients, including diffuse alveolar hemorrhage (DAH), idiopathic pneumonia syndrome (IPS), bronchiolitis obliterans syndrome (BO or BOS), and cryptogenic organizing pneumonia (COP).

Original languageEnglish (US)
Title of host publicationBlood and Marrow Transplant Handbook
Subtitle of host publicationComprehensive Guide for Patient Care
PublisherSpringer New York
Number of pages12
ISBN (Print)9781441975058
StatePublished - 2011

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Pulmonary complications'. Together they form a unique fingerprint.

Cite this